This Article Full Text (PDF) Submit a related Letter to the Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by CARLSSON, L. M. S. Articles by WONG, W. L. T. Search for Related Content PubMed PubMed Citation Articles by CARLSSON, L. M. S. Articles by WONG, W. L. T.

Ligand-Mediated Immunofunctional Assay for Quantitation of Growth Hormone-Binding Protein in Human Blood

Departments of Immunology Research and Assay Technologies Genentech, Inc. South San Francisco, California 94080
Developmental Biology Genentech, Inc. South San Francisco, California 94080
Clinical Research Genentech, Inc. South San Francisco, California 94080

Address requests for reprints to: Dr. Wai Lee T. Wong, Genentech, Inc., South San Francisco, California 94080.

Human serum contains a high affinity GHbinding protein (GHBP) whose amino-terminal sequence is identical to the extracellular domain of the GH receptor. Current methods that measure GHBP are laborious, require size or charcoal separation of the GH/GHBP complex, and may be influenced by ambient GH concentrations. We have developed a novel assay method that allows quantitation of the total amount of functional GHBP in serum or plasma. The assay can also be used to measure the concentration of the circulating GH/ GHBP complex. An anti-GHBP monoclonal antibody, which recognizes both free GHBP and GH-bound GHBP, is used to capture the GHBP on a microtiter plate. Recombinant human GH is added to saturate all binding sites, and an anti-GH antibody conjugated with horseradish peroxidase is used to detect the amount of GH (endogenous and exogenous) bound to the GHBP. The same procedure, but without incubation with GH, allows measurement of the endogenous GH/GHBP complex. The assay is sensitive (detection range, 31–2000 pmol/L), with average inter- and intraassay precisions of 11.3% and 7.3%, respectively. Measurements in random blood samples from 16 healthy adults showed that all subjects had clearly detectable GHBP concentrations (range, 65.8–305.6 pmol/L). In contrast, GHBP levels were undetectable in samples from 2 patients with Laron-type dwarfism. We believe that this ligand-mediated immunofunctional assay, which combines the simplicity and specificity of an enzyme-linked immunosorbent assay with the ability to detect only biochemically active binding protein, will be useful for studies of the role of the GHBP in health and disease.

^* Genentech Postdoctoral Fellow, supported in part by the Royal Swedish Academy of Sciences and the Swedish Medical Research Council.

Received March 5, 1991.

This article has been cited by other articles:

				D. Nemet, A. Eliakim, F. Zaldivar, and D. M. Cooper Effect of rhIL-6 infusion on GH->IGF-I axis mediators in humans Am J Physiol Regulatory Integrative Comp Physiol, December 1, 2006; 291(6): R1663 - R1668. [Abstract] [Full Text] [PDF]

				M. Bidlingmaier, J. Kim, C. Savoy, M. J. Kim, N. Ebrecht, S. de la Motte, and C. J. Strasburger Comparative Pharmacokinetics and Pharmacodynamics of a New Sustained-Release Growth Hormone (GH), LB03002, Versus Daily GH in Adults with GH Deficiency J. Clin. Endocrinol. Metab., August 1, 2006; 91(8): 2926 - 2930. [Abstract] [Full Text] [PDF]

				R. A. Feelders, M. Bidlingmaier, C. J. Strasburger, J. A. M. J. L. Janssen, P. Uitterlinden, L. J. Hofland, S. W. J. Lamberts, A. J. van der Lely, and W. W. de Herder Postoperative Evaluation of Patients with Acromegaly: Clinical Significance and Timing of Oral Glucose Tolerance Testing and Measurement of (Free) Insulin-Like Growth Factor I, Acid-Labile Subunit, and Growth Hormone-Binding Protein Levels J. Clin. Endocrinol. Metab., December 1, 2005; 90(12): 6480 - 6489. [Abstract] [Full Text] [PDF]

				A. R. Hoffman, C. J. Strasburger, A. Zagar, W. F. Blum, A. Kehely, and M. L. Hartman Efficacy and Tolerability of an Individualized Dosing Regimen for Adult Growth Hormone Replacement Therapy in Comparison with Fixed Body Weight-Based Dosing J. Clin. Endocrinol. Metab., July 1, 2004; 89(7): 3224 - 3233. [Abstract] [Full Text] [PDF]

				J. Pantel, J. Grulich-Henn, M. Bettendorf, C. J. Strasburger, U. Heinrich, and S. Amselem Heterozygous Nonsense Mutation in Exon 3 of the Growth Hormone Receptor (GHR) in Severe GH Insensitivity (Laron Syndrome) and the Issue of the Origin and Function of the GHRd3 Isoform J. Clin. Endocrinol. Metab., April 1, 2003; 88(4): 1705 - 1710. [Abstract] [Full Text] [PDF]

				J. Kratzsch, A. Lammert, A. Bottner, B. Seidel, G. Mueller, J. Thiery, J. Hebebrand, and W. Kiess Circulating Soluble Leptin Receptor and Free Leptin Index during Childhood, Puberty, and Adolescence J. Clin. Endocrinol. Metab., October 1, 2002; 87(10): 4587 - 4594. [Abstract] [Full Text] [PDF]

				Z. Wu, M. Bidlingmaier, C. Liu, E. B. De Souza, M. Tschop, K. M. Morrison, and C. J. Strasburger Quantification of the Soluble Leptin Receptor in Human Blood by Ligand-Mediated Immunofunctional Assay J. Clin. Endocrinol. Metab., June 1, 2002; 87(6): 2931 - 2939. [Abstract] [Full Text] [PDF]

				P. TIRAKITSOONTORN, E. NUSSBAUM, C. MOSER, M. HILL, and D. M. COOPER Fitness, Acute Exercise, and Anabolic and Catabolic Mediators in Cystic Fibrosis Am. J. Respir. Crit. Care Med., October 15, 2001; 164(8): 1432 - 1437. [Abstract] [Full Text] [PDF]

				A. Eliakim, T. P. Scheett, R. Newcomb, S. Mohan, and D. M. Cooper Fitness, Training, and the Growth Hormone{->}Insulin-Like Growth Factor I Axis in Prepubertal Girls J. Clin. Endocrinol. Metab., June 1, 2001; 86(6): 2797 - 2802. [Abstract] [Full Text] [PDF]

				M. Ishikawa, A. Nimura, R. Horikawa, N. Katsumata, O. Arisaka, M. Wada, M. Honjo, and T. Tanaka A Novel Specific Bioassay for Serum Human Growth Hormone J. Clin. Endocrinol. Metab., November 1, 2000; 85(11): 4274 - 4279. [Abstract] [Full Text]

				P. C. Hindmarsh, E. Dennison, S. M. Pincus, C. Cooper, C. H. D. Fall, D. R. Matthews, P. J. Pringle, and C. G. D. Brook A Sexually Dimorphic Pattern of Growth Hormone Secretion in the Elderly J. Clin. Endocrinol. Metab., August 1, 1999; 84(8): 2679 - 2685. [Abstract] [Full Text]

				T. C J Sas, S M P F d. M. Keizer-Schrama, T. Stijnen, A van Teunenbroek, A C S Hokken-Koelega, J J J Waelkens, G G Massa, T. Vulsma, W J Gerver, H M Reeser, et al. Final height in girls with Turner's syndrome treated with once or twice daily growth hormone injections Arch. Dis. Child., January 1, 1999; 80(1): 36 - 41. [Abstract] [Full Text]

				J. E. Sanchez, E. Perera, L. Baumbach, and W. W. Cleveland Growth Hormone Receptor Mutations in Children with Idiopathic Short Stature J. Clin. Endocrinol. Metab., November 1, 1998; 83(11): 4079 - 4083. [Abstract] [Full Text]

				E. S. Kurland, F. K. W. Chan, C. J. Rosen, and J. P. Bilezikian Normal Growth Hormone Secretory Reserve in Men with Idiopathic Osteoporosis and Reduced Circulating Levels of Insulin-Like Growth Factor-I J. Clin. Endocrinol. Metab., July 1, 1998; 83(7): 2576 - 2579. [Abstract] [Full Text]

				A. Eliakim, J. A. Brasel, S. Mohan, W. L. T. Wong, and D. M. Cooper Increased physical activity and the growth hormone-IGF-I axis in adolescent males Am J Physiol Regulatory Integrative Comp Physiol, July 1, 1998; 275(1): R308 - R314. [Abstract] [Full Text] [PDF]

				R. Bjarnason, R. Wickelgren, M. Hermansson, F. Hammarqvist, B. Carlsson, and L. M. S. Carlsson Growth Hormone Treatment Prevents the Decrease in Insulin-Like Growth Factor I Gene Expression in Patients Undergoing Abdominal Surgery J. Clin. Endocrinol. Metab., May 1, 1998; 83(5): 1566 - 1572. [Abstract] [Full Text]

				G. A. Laughlin, C. E. Dominguez, and S. S. C. Yen Nutritional and Endocrine-Metabolic Aberrations in Women with Functional Hypothalamic Amenorrhea J. Clin. Endocrinol. Metab., January 1, 1998; 83(1): 25 - 32. [Abstract] [Full Text]

				C. Fall, P. Hindmarsh, E. Dennison, S. Kellingray, D. Barker, and C. Cooper Programming of Growth Hormone Secretion and Bone Mineral Density in Elderly Men: A Hypothesis J. Clin. Endocrinol. Metab., January 1, 1998; 83(1): 135 - 139. [Abstract] [Full Text]

				P. C. Hindmarsh, C. H. D. Fall, P. J. Pringle, C. Osmond, and C. G. D. Brook Peak and Trough Growth Hormone Concentrations Have Different Associations with the Insulin-Like Growth Factor Axis, Body Composition, and Metabolic Parameters J. Clin. Endocrinol. Metab., July 1, 1997; 82(7): 2172 - 2176. [Abstract] [Full Text] [PDF]

				R. Barnard, F.-y. Chan, and H. D. McIntyre Growth Hormone-Binding Protein in Normal and Pathologic Gestation: Correlations with Maternal Diabetes and Fetal Growth J. Clin. Endocrinol. Metab., June 1, 1997; 82(6): 1879 - 1884. [Abstract] [Full Text] [PDF]

				C. Jansson, C. Boguszewski, S. Rosberg, L. Carlsson, and K. Albertsson-Wikland Growth hormone (GH) assays: influence of standard preparations, GH isoforms, assay characteristics, and GH-binding protein Clin. Chem., June 1, 1997; 43(6): 950 - 956. [Abstract] [Full Text] [PDF]

				O. Khorram, G. A. Laughlin, and S. S. C. Yen Endocrine and Metabolic Effects of Long-Term Administration of [Nle27]Growth Hormone-Releasing Hormone-(1-29)-NH2 in Age-Advanced Men and Women J. Clin. Endocrinol. Metab., May 1, 1997; 82(5): 1472 - 1479. [Abstract] [Full Text] [PDF]

				B. Tonshoff, M. J. Cronin, M. Reichert, D. Haffner, A.-M. Wingen, W. F. Blum, and O. Mehls Reduced Concentration of Serum Growth Hormone (GH)-Binding Protein in Children with Chronic Renal Failure: Correlation with GH Insensitivity J. Clin. Endocrinol. Metab., April 1, 1997; 82(4): 1007 - 1013. [Abstract] [Full Text] [PDF]

				M. Boguszewski, R. Bjarnason, S. Rosberg, L. M. S. Carlsson, and K. Albertsson-Wikland Growth Hormone (GH)-Binding Protein in Prepubertal Short Children Born Small for Gestational Age: Effects of Growth Hormone Treatment J. Clin. Endocrinol. Metab., April 1, 1997; 82(4): 1014 - 1019. [Abstract] [Full Text] [PDF]

				M. Hermansson, R. B. Wickelgren, F. Hammarqvist, R. Bjarnason, I. Wennstrom, J. Wernerman, B. Carlsson, and L. M. S. Carlsson Measurement of Human Growth Hormone Receptor Messenger Ribonucleic Acid by a Quantitative Polymerase Chain Reaction-Based Assay: Demonstration of Reduced Expression after Elective Surgery J. Clin. Endocrinol. Metab., February 1, 1997; 82(2): 421 - 428. [Abstract] [Full Text] [PDF]

				L. Baumbach, A. Schiavi, R. Bartlett, E. Perera, J. Day, M. R. Brown, S. Stein, M. Eidson, J. S. Parks, and W. Cleveland Clinical, Biochemical, and Molecular Investigations of a Genetic Isolate of Growth Hormone Insensitivity (Laron's Syndrome) J. Clin. Endocrinol. Metab., February 1, 1997; 82(2): 444 - 451. [Abstract] [Full Text] [PDF]

				S. Fisker, N. Vahl, J. O. L. Jorgensen, J. S. Christiansen, and H. Orskov Abdominal Fat Determines Growth Hormone-Binding Protein Levels in Healthy Nonobese Adults J. Clin. Endocrinol. Metab., January 1, 1997; 82(1): 123 - 128. [Abstract] [Full Text] [PDF]

				A. D. Goddard, R. Covello, S.-M. Luoh, T. Clackson, K. M. Attie, N. Gesundheit, A. C. Rundle, J. A. Wells, L. M.S. Carlsson, and The Growth Hormone Insensitivity Study Group Mutations of the Growth Hormone Receptor in Children with Idiopathic Short Stature N. Engl. J. Med., October 26, 1995; 333(17): 1093 - 1098. [Abstract] [Full Text] [PDF]